Landscapes / Companies
Nanjing Chia-tai Tianqing Pharmaceutical not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
1 in Phase 2
Drugs
5
in active trials · 6 in all
Trials
9 active
16 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Nov 2026soonPhase 3 trial completes | |||
| Next date | Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Paroxysmal Nocturnal Hemoglobinuria, Primary IgA Nephropathy | ||||
| Open drug page | |||||
Ramelteonnot checked |
Melatonin receptor agonist |
Phase 3 | Dec 2026Phase 3 trial completes | ||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Chronic Insomnia | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Aug 2028Phase 3 trial completes | |||
| Next date | 31 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 May 2027Phase 1/2 trial completes | |||
| Next date | 31 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | TED, Thyroid Eye Disease | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2027Phase 1 trial completes | |||
| Next date | Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Acromegaly | ||||
| Open drug page | |||||
About
- No active trial
- NTQ2494
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021